Friday, November 26

What is the experimental treatment of Donald Trump | Digital Trends Spanish

US President Donald Trump received a dose of an experimental treatment to combat COVID-19, the White House confirmed on Friday, October 2.

Trump and his wife Melania underwent coronavirus tests after one of his closest advisers to the president confirmed that he had been infected with SARS-CoV-2.

The 74-year-old president was transferred on Friday afternoon, October 2, to Walter Reed military hospital, As a precautionary measure.

What is the Regeneron

Trump’s doctor, Sean Conley, confirmed that Trump received a cocktail of antibodies that is being tested by Regeneron Pharmaceuticals Inc.

An update from President @realDonaldTrump& # 39; s physician:

& mdash; Kayleigh McEnany (@PressSec) October 2, 2020

The company has reported that it can improve symptoms in COVID-19 patients who have not required hospitalization, without causing serious side effects in trials.

Monoclonal antibodies, that is, manufactured copies of human antibodies against the virus, are one of the most anticipated types of experimental drugs against COVID-19

The injected antibodies are designed to begin fighting the virus immediately and are being developed to prevent and treat COVID-19, Reuters reported.

The technique is already widely used to treat a variety of diseases.

Drug cocktail

Trump’s doctor said the president is taking various medications. The Reuters agency detailed the drugs, as well as their potential benefits:

  • Vitamin D and mineral zinc: strengthens and stimulates the immune system.
  • Famotidine: a medicine for heartburn. It has not been shown to work against COVID-19, but researchers are studying it as a potential treatment.
  • Melatonin – A drug often given to help you sleep.
  • Aspirin: can help prevent heart attacks and reduce fever. Trump has said he takes it daily.

Editor’s Recommendations